Clinical Trials Browser

Withdrawn × Neoplasm Metastasis × orteronel × Clear all

NCT01658527 2016-06-10

TAK-700 in Castration Resistant Prostate Cancer

Phase 2 Withdrawn

Neoplasm Metastasis, Prostatic Neoplasms

NCT02054793 2014-07-23

Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)

Phase 1/2 Withdrawn

Neoplasm Metastasis, Prostatic Neoplasms